Across diverse geographic regions and clinical presentations—ranging from ambulatory chronic heart failure to acutely decompensated states—elevated baseline or persistent levels of IL-6, hs-CRP, and the neutrophil-to-lymphocyte ratio uniformly associate with increased risk of mortality, cardiovascular death, and recurrent heart failure hospitalizations. Here, IL6 is linked to heart failure.